GO:1905872 negative regulation of protein localization to cell leading edge: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905872 describes any process that stops, prevents or reduces the frequency, rate or extent of protein localization to the cell leading edge.
• It is a biological_process term that acts as a negative regulator of leading-edge protein accumulation, often by modulating Rho GTPase signaling.
• Key proteins include p190RhoGAP (ARHGAP35), Myo9b, Rac1, and Ena/VASP proteins, which control actin dynamics and protrusion stability.
• Dysregulation of this process contributes to cancer cell invasion, metastasis, and developmental defects such as neural crest migration disorders.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of genes in this process.
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to study negative regulation of protein localization to cell leading edge.
Description
The cell leading edge is a highly dynamic region that drives cell migration, invasion, and morphogenesis. Protein localization to this region must be tightly controlled to ensure proper actin polymerization and adhesion turnover. GO:1905872, negative regulation of protein localization to cell leading edge, encompasses the mechanisms that restrict or reduce the accumulation of specific proteins at the leading edge. This process is critical for maintaining directional migration and preventing aberrant protrusive activity. Researchers study this term to understand how cells polarize, how Rho GTPases are spatiotemporally regulated, and how dysregulation leads to diseases such as cancer and developmental disorders. The QuickGO definition states: Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge. This article synthesizes published literature to provide a comprehensive overview of the molecular players, regulatory mechanisms, and experimental approaches relevant to GO:1905872.
negative regulation of protein localization to cell leading edge At A Glance
| GO ID | GO:1905872 |
|---|---|
| GO term | negative regulation of protein localization to cell leading edge |
| Ontology | biological_process |
| Synonym | inhibition of protein localization to cell leading edge; downregulation of protein localization to cell leading edge; negative regulation of protein localisation to cell leading edge |
| Major function | Restricts or reduces the accumulation of proteins at the leading edge to control cell migration and protrusion dynamics |
| Related cellular component | cell leading edge, lamellipodium, filopodium, focal adhesions |
| Related molecular function | Rho GTPase activator activity, actin binding, motor activity |
| Key regulators | p190RhoGAP (ARHGAP35), Myo9b, Rac1, Ena/VASP proteins |
| Disease relevance | Cancer invasion and metastasis, neural crest migration defects, developmental disorders |
What Is GO:1905872?
GO:1905872 is a biological_process term defined as any process that stops, prevents or reduces the frequency, rate or extent of protein localization to the cell leading edge. In other words, it covers molecular events that negatively regulate the delivery, retention, or accumulation of proteins at the leading edge of a migrating cell. This includes the action of Rho GTPase-activating proteins (GAPs) that locally inhibit Rac or Rho activity, thereby preventing excessive actin polymerization or protrusion formation.
Why Is negative regulation of protein localization to cell leading edge Important in Cell Biology?
Understanding GO:1905872 is essential because the leading edge is the command center for cell motility, and its dysregulation is a hallmark of cancer metastasis and developmental abnormalities. Negative regulation ensures that protrusive activity is balanced, preventing uncontrolled migration. For example, p190RhoGAP locally inhibits RhoA at the leading edge, and its loss leads to increased motility and invasion. Similarly, Myo9b acts as a RhoGAP to constrain Rac activity and limit protrusion. Ena/VASP proteins are negative regulators of fibroblast motility, and their removal enhances speed but reduces directionality. Thus, this process is a key node for therapeutic intervention in diseases where cell migration is pathological.
• Controls directional cell migration and chemotaxis by restricting protein accumulation at the leading edge.
• Regulates actin cytoskeleton dynamics through Rho GTPase signaling.
• Prevents excessive protrusion formation and maintains cell shape.
• Its dysregulation promotes cancer cell invasion and metastasis.
• Plays a role in embryonic development, particularly neural crest migration.
• Influences wound healing and tissue regeneration by modulating cell motility.
• Serves as a target for anti-metastatic therapies.
• Provides mechanistic insights into Rho GTPase spatiotemporal regulation.
• Helps understand how cells integrate adhesion and signaling cues.
• Is critical for proper immune cell trafficking and inflammatory responses.
What Happens During negative regulation of protein localization to cell leading edge?
Local Inhibition of Rho GTPase Activity
In simple terms: Proteins that stop Rho GTPases at the leading edge prevent them from pulling actin too much.
A primary mechanism of GO:1905872 is the local inhibition of Rho GTPase activity at the leading edge. p190RhoGAP (ARHGAP35) is a RhoGAP that specifically inactivates RhoA at the leading edge of migrating cells, thereby reducing actomyosin contractility and allowing protrusion. Similarly, Myo9b, an unconventional myosin with RhoGAP activity, locally regulates RhoA to control cell motility. These GAPs act as negative regulators by preventing the accumulation of active RhoA at the leading edge, which would otherwise promote excessive stress fiber formation and retract protrusions.
Negative Feedback on Rac Activity
In simple terms: Rac is a protein that pushes the cell forward, but too much Rac causes chaotic movement; negative feedback keeps it in check.
Rac1 is a key regulator of lamellipodia formation, but its activity must be locally dampened to allow proper guidance. Town et al. (2023) demonstrated that local negative feedback of Rac activity at the leading edge underlies a pilot pseudopod-like program for amoeboid cell guidance. This feedback involves the recruitment of RacGAPs or other inhibitory molecules that reduce Rac activity, preventing excessive protrusion and enabling cells to respond to directional cues. This negative regulation is essential for maintaining a single leading edge and efficient chemotaxis.
Regulation of Actin Polymerization Machinery
In simple terms: Proteins like Ena/VASP help actin grow, but when they are removed from the leading edge, actin growth slows down.
Ena/VASP proteins are actin elongation factors that localize to the leading edge and promote protrusion. However, they can also act as negative regulators of fibroblast motility; Bear et al. (2000) showed that Ena/VASP proteins negatively regulate fibroblast motility by preventing the formation of multiple competing protrusions. The negative regulation of their localization to the leading edge, or their local inhibition, is a mechanism to control actin polymerization rates and maintain directional persistence. This is a classic example of GO:1905872, where reducing the localization of a protein (Ena/VASP) to the leading edge modulates cell movement.
Adhesion-Dependent Wave Generation
In simple terms: Adhesions to the surface can trigger waves of proteins that stop or slow down movement at the front.
Barnhart et al. (2017) described adhesion-dependent wave generation in crawling cells, where waves of actin and adhesion proteins propagate and can negatively regulate leading-edge protrusion. These waves act as a spatial-temporal mechanism to reduce the localization of protrusive proteins at the leading edge, contributing to GO:1905872. The interplay between adhesion and negative regulation ensures that protrusions are transient and can be retracted or redirected.
Co-Regulatory Circuits with Cas and BCAR3
In simple terms: Two proteins, Cas and BCAR3, work together to control the dynamics of the leading edge.
Steenkiste et al. (2021) identified a Cas-BCAR3 co-regulatory circuit that controls lamellipodia dynamics. This circuit involves negative regulation of protein localization to the leading edge, as Cas and BCAR3 modulate the recruitment of proteins that either promote or inhibit protrusion. Disruption of this circuit leads to altered lamellipodia dynamics, highlighting the importance of negative regulation in maintaining proper leading-edge architecture.
Key Genes Involved in GO:1905872 negative regulation of protein localization to cell leading edge
The following genes and proteins are central to the negative regulation of protein localization to the cell leading edge, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ARHGAP35 (p190RhoGAP) | RhoGAP that inactivates RhoA at the leading edge | Regulates cell motility and invasion; loss promotes migration |
| MYO9B | Unconventional myosin with RhoGAP activity | Local regulation of RhoA to control motility |
| RAC1 | Rho GTPase promoting lamellipodia | Subject to local negative feedback for guidance |
| ENAH (Mena) | Ena/VASP family actin regulator | Negative regulator of fibroblast motility |
| VASP | Ena/VASP family actin regulator | Negative regulator of fibroblast motility |
| BCAR3 | Adapter protein in Cas-BCAR3 circuit | Controls lamellipodia dynamics |
| BCAR1 (Cas) | Docking protein in focal adhesions | Co-regulates lamellipodia with BCAR3 |
| RHOA | Rho GTPase promoting actomyosin contractility | Inhibited by p190RhoGAP and Myo9b |
| CDC42 | Rho GTPase regulating filopodia | Potential target of negative regulation at leading edge |
| WASF1 (WAVE1) | Actin nucleation promoting factor | Regulated by Rac and negative feedback |
| WASF2 (WAVE2) | Actin nucleation promoting factor | Regulated by Rac and negative feedback |
| NCK1 | Adapter protein linking receptors to actin | May be involved in leading-edge protein localization |
| ABL1 | Non-receptor tyrosine kinase | Regulates actin dynamics and adhesion |
| PTK2 (FAK) | Focal adhesion kinase | Integrates adhesion signals at leading edge |
| SRC | Tyrosine kinase | Regulates adhesion turnover and protrusion |
| PIK3CA | PI3K catalytic subunit | Produces PIP3 at leading edge, can be negatively regulated |
| PTEN | Lipid phosphatase | Negatively regulates PIP3 localization at leading edge |
| CDH1 (E-cadherin) | Cell-cell adhesion molecule | May influence leading-edge protein localization in collective migration |
How Is negative regulation of protein localization to cell leading edge Regulated?
The negative regulation of protein localization to the cell leading edge is itself tightly regulated by upstream signals. Non-canonical Wnt-planar cell polarity (PCP) pathway components control the asymmetric localization of proteins at the leading edge during neural crest migration. This pathway regulates Rho GTPase activity and actin dynamics, thereby influencing GO:1905872. Additionally, local negative feedback loops, such as those involving RacGAPs, are modulated by guidance cues and adhesion receptors. The Cas-BCAR3 circuit is regulated by integrin signaling and Src family kinases. These regulatory inputs ensure that negative regulation is spatially and temporally precise, allowing cells to respond dynamically to their environment.
negative regulation of protein localization to cell leading edge and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ARHGAP35 | Cancer invasion and metastasis | Knockout in MDA-MB-231 cells; invasion assays |
| MYO9B | Cancer cell motility | Knockdown or knockout in HeLa cells; live imaging |
| RAC1 | Metastasis, developmental defects | Point mutation (constitutively active) knock-in in zebrafish |
| BCAR3 | Breast cancer, lamellipodia dynamics | Knockout in MCF10A cells; 3D migration assays |
| ENAH/VASP | Cell motility disorders | Overexpression in fibroblasts; wound healing assays |
Cancer Invasion and Metastasis
Dysregulation of GO:1905872 is strongly linked to cancer progression. Loss of p190RhoGAP (ARHGAP35) leads to increased RhoA activity at the leading edge, promoting cell motility and invasion. In breast cancer, the BCSC-1 interactome, which includes proteins involved in leading-edge dynamics, is altered, contributing to cancer stem cell behavior. Similarly, Myo9b downregulation enhances Rac activity and protrusion, facilitating metastasis. Therefore, restoring negative regulation at the leading edge is a potential therapeutic strategy to limit cancer spread.
Developmental Disorders
Proper neural crest migration depends on the non-canonical Wnt-PCP pathway, which regulates protein localization at the leading edge. Disruption of this negative regulation can lead to craniofacial defects and other developmental anomalies. For example, mutations in genes controlling Rho GTPase activity at the leading edge are associated with developmental syndromes characterized by impaired cell migration.
Inflammatory and Immune Cell Trafficking
Immune cells rely on precise leading-edge dynamics to migrate to sites of infection. Negative regulation of protein localization to the leading edge ensures that neutrophils and macrophages move directionally. Dysregulation can lead to chronic inflammation or immunodeficiency. Although specific genes are less studied, the principles of GO:1905872 apply to immune cell motility.
From negative regulation of protein localization to cell leading edge-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ARHGAP35 increase leading-edge RhoA and invasion? | CRISPR knockout of ARHGAP35 in cancer cell lines |
| How does a specific point mutation in RAC1 affect negative feedback? | CRISPR knock-in of RAC1 mutant in iPSCs or cancer cells |
| Where and when is Myo9b localized at the leading edge? | Knock-in of fluorescent tag (e.g., GFP) at MYO9B locus |
| Does overexpression of Ena/VASP reduce cell speed? | Overexpression of ENAH/VASP in fibroblasts |
| What genes are essential for negative regulation in migration? | Genome-wide CRISPR library screening in migrating cells |
| How does BCAR3 phosphorylation affect lamellipodia dynamics? | Point mutation knock-in of BCAR3 phospho-sites |
How to Study the negative regulation of protein localization to cell leading edge Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TIRF microscopy | Real-time protein localization at leading edge | Visualizing Rac1 or Myo9b dynamics |
| CRISPR knockout screen | Genes affecting cell migration | Identifying negative regulators |
| AP-MS | Protein-protein interactions | Mapping BCSC-1 interactome |
| GST-Rhotekin pulldown | Active RhoA levels | Measuring p190RhoGAP activity |
| PAK-PBD pulldown | Active Rac1 levels | Assessing negative feedback |
| Live-cell wound healing assay | Cell migration speed and directionality | Evaluating Ena/VASP overexpression |
| Phospho-proteomics | Signaling changes at leading edge | Identifying regulatory phosphorylation |
| FRET biosensors | Local GTPase activity | Visualizing Rac1 and RhoA at leading edge |
Live-Cell Imaging and Fluorescence Microscopy
Live-cell imaging is essential to study the dynamics of protein localization at the leading edge. Total internal reflection fluorescence (TIRF) microscopy and spinning-disk confocal microscopy allow visualization of fluorescently tagged proteins (e.g., GFP-Rac1, mCherry-Myo9b) in migrating cells. This method reveals real-time changes in protein accumulation and can quantify negative regulation events.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that negatively regulate protein localization to the leading edge. Cells are subjected to a migration assay, and sgRNA enrichment is analyzed by next-generation sequencing. This approach has been used to uncover regulators of lamellipodia dynamics.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can map the interactome of leading-edge proteins. For example, the BCSC-1 interactome in breast cancer was mapped to identify proteins involved in negative regulation. Proximity labeling (BioID) can also identify nearby proteins at the leading edge.
Biochemical Assays for GTPase Activity
Rho GTPase activity can be measured using GST-Rhotekin or PAK-PBD pulldown assays followed by Western blotting. These assays quantify active RhoA or Rac1 levels in cell lysates, providing biochemical evidence of negative regulation.
How CRISPR Can Be Used to Study GO:1905872 negative regulation of protein localization to cell leading edge
Knockout
CRISPR knockout is used to completely abolish the function of genes involved in negative regulation, such as ARHGAP35 or MYO9B. This allows researchers to observe the consequences of losing negative regulation on leading-edge protein localization and cell migration. For example, ARHGAP35 knockout cells exhibit increased RhoA at the leading edge and enhanced invasion.
Point Mutation
Point mutation knock-in via CRISPR can mimic disease-associated mutations or phospho-null/phospho-mimetic variants. For instance, mutating the catalytic arginine of p190RhoGAP abolishes its GAP activity, leading to constitutive RhoA activation at the leading edge. This approach helps dissect the specific contribution of enzymatic activity to GO:1905872.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) at endogenous loci allows real-time visualization of protein localization without overexpression artifacts. Tagging MYO9B or RAC1 enables tracking of their dynamics at the leading edge and assessing how negative regulation is perturbed by other mutations.
Overexpression
Overexpression of negative regulators, such as p190RhoGAP or Ena/VASP, can enhance negative regulation and reduce cell motility. This is useful to test sufficiency of a gene in stopping protein localization to the leading edge. For example, Ena/VASP overexpression reduces fibroblast speed.
How EDITGENE Supports negative regulation of protein localization to cell leading edge Research
Researchers studying negative regulation of protein localization to cell leading edge-related genes often need to determine whether a candidate gene is causally involved in controlling leading-edge dynamics, and to dissect the precise molecular mechanisms. This requires robust genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such research.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of protein localization to cell leading edge research.
Frequently Asked Questions About negative regulation of protein localization to cell leading edge
What is GO:1905872?
GO:1905872 is a Gene Ontology biological_process term defined as any process that stops, prevents or reduces the frequency, rate or extent of protein localization to the cell leading edge.
What genes are involved in negative regulation of protein localization to cell leading edge?
Key genes include ARHGAP35 (p190RhoGAP), MYO9B, RAC1, ENAH, VASP, BCAR3, and BCAR1, which regulate Rho GTPase signaling and actin dynamics at the leading edge.
How does p190RhoGAP regulate the leading edge?
p190RhoGAP is a RhoGAP that inactivates RhoA at the leading edge, reducing actomyosin contractility and preventing excessive protrusion, thereby negatively regulating protein localization.
What is the role of Myo9b in cell motility?
Myo9b is an unconventional myosin with RhoGAP activity that locally regulates RhoA at the leading edge to control cell motility and protrusion dynamics.
How does Rac1 negative feedback work at the leading edge?
Local negative feedback of Rac activity involves RacGAPs that reduce Rac1 activity, preventing excessive lamellipodia formation and enabling directional guidance.
Why is negative regulation of protein localization important for cancer?
Loss of negative regulation leads to increased Rho GTPase activity at the leading edge, promoting cancer cell invasion and metastasis.
What experimental models are used to study GO:1905872?
CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression cell models, combined with live-cell imaging and biochemical assays, are commonly used.
How can CRISPR screening identify regulators of leading-edge protein localization?
Genome-wide CRISPR knockout or activation screens coupled with migration assays can identify genes that negatively regulate protein localization to the leading edge.
What diseases are associated with dysregulation of leading-edge protein localization?
Cancer metastasis, developmental disorders such as neural crest migration defects, and inflammatory conditions are associated with dysregulation of this process.
What services does EDITGENE offer for studying GO:1905872?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services to study negative regulation of protein localization to cell leading edge.
Conclusion
GO:1905872, negative regulation of protein localization to cell leading edge, is a critical biological process that ensures proper cell migration and protrusion dynamics. Through the action of Rho GTPases, GAPs, and actin regulators, cells tightly control which proteins accumulate at the leading edge. Dysregulation of this process contributes to cancer metastasis and developmental disorders. Advances in CRISPR-based models and imaging techniques continue to unravel the molecular mechanisms, offering potential therapeutic targets. EDITGENE's comprehensive services empower researchers to dissect this process with precision and speed.
References
- 1. Bidaud-Meynard A et al.. 2019. Regulation of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP.. Small GTPases 10(2):99-110 PMID: 28287334
- 2. Town JP et al.. 2023. Local negative feedback of Rac activity at the leading edge underlies a pilot pseudopod-like program for amoeboid cell guidance.. PLoS Biol 21(9):e3002307 PMID: 37747905
- 3. Ma Y et al.. 2025. Mapping the BCSC-1 interactome in breast cancer.. Sci Rep 15(1):36728 PMID: 41120661
- 4. Bear JE et al.. 2000. Negative regulation of fibroblast motility by Ena/VASP proteins.. Cell 101(7):717-28 PMID: 10892743
- 5. Hemkemeyer SA et al.. 2021. Local Myo9b RhoGAP activity regulates cell motility.. J Biol Chem 296:100136 PMID: 33268376
- 6. Barnhart EL et al.. 2017. Adhesion-Dependent Wave Generation in Crawling Cells.. Curr Biol 27(1):27-38 PMID: 27939309
- 7. Mayor R et al.. 2014. The role of the non-canonical Wnt-planar cell polarity pathway in neural crest migration.. Biochem J 457(1):19-26 PMID: 24325550
- 8. Steenkiste EM et al.. 2021. A Cas-BCAR3 co-regulatory circuit controls lamellipodia dynamics.. Elife 10 PMID: 34169835
